Close Menu

herpes

Focus Diagnostics, a Quest Diagnostics subsidiary, is aiming to receive US Food and Drug Administration approval in 2014 for a number of direct-from-specimen Simplexa-branded molecular diagnostic tests for the 3M Integrated Cycler, a company official said recently.

A team from Cornell University and Cornell Weill Medical College has received a grant from the National Institute of Biomedical Imaging and Bioengineering to support early clinical development and validation of its solar-powered, point-of-care PCR to enable electricity-free diagn

Researchers last week provided a glimpse of the clinical performance of a trio of extraction-free molecular assays currently being developed by clinical diagnostics firm Quidel.

Scientists from Cornell University and Cornell Weill Medical College are developing a solar-powered, point-of-care PCR system that has the potential to enable electricity-free molecular diagnostics in resource-poor areas of the world.

BioHelix is developing a low-cost, handheld, real-time fluorescence detection system capable of running assays based on the company's isothermal helicase-dependent amplification technology, the company disclosed this week.

IMDx said this week that it has received CE marking for its HSV-1/2 assay for use on the Abbott m2000 System.

Luminex this week made a play for the low- to mid-volume molecular diagnostic testing market by when it announced that it is acquiring privately held molecular diagnostics developer GenturaDx for $50 million.

NEW YORK (GenomeWeb News) – A study online today in Science hints that the live, attenuated viruses used in some vaccines may be able to recombine in their hosts in rare cases, producing viruses that are once again able to cause infection.

Scientists from the Keck Graduate Institute of Applied Life Sciences and KGI spinout Claremont Biosolutions have been developing point-of-care molecular testing platforms and associated assays for Clostridium difficile, multi-drug-resistant tuberculosis, and herpes simpl

Pages

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.